Matthew M. Roden

439 total citations
10 papers, 369 citations indexed

About

Matthew M. Roden is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Matthew M. Roden has authored 10 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Matthew M. Roden's work include Immunotherapy and Immune Responses (6 papers), vaccines and immunoinformatics approaches (3 papers) and CAR-T cell therapy research (3 papers). Matthew M. Roden is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), vaccines and immunoinformatics approaches (3 papers) and CAR-T cell therapy research (3 papers). Matthew M. Roden collaborates with scholars based in United States, Malaysia and United Kingdom. Matthew M. Roden's co-authors include Monica C. Panelli, Francesco M. Marincola, Christina J. Kim, Maria Bettinotti, Francesco M. Marincola, Patricia Fetsch, Steven A. Rosenberg, Nicholas P. Restifo, S A Rosenberg and Adam I. Riker and has published in prestigious journals such as The Journal of Immunology, Journal of Immunological Methods and Annals of Surgical Oncology.

In The Last Decade

Matthew M. Roden

10 papers receiving 357 citations

Peers

Matthew M. Roden

IMMUN

MB

ONCOL

GENET

RNMI

Nicole Lévy Switzerland

H Stauss United Kingdom

Jean-Philippe Blanck United States

Jingjing She United States

Robert J. Hoyer United States

Joanne P. McLaughlin United States

Navreet K. Nanda United States

J. Roszkowski United States

C Havele Canada

Anita Kant United States

Nicole Lévy Switzerland

Matthew M. Roden

334 ×1.1

IMMUN

217 ×1.4

MB

151 ×1.2

ONCOL

59 ×1.1

GENET

15 ×0.5

RNMI

Citations per year, relative to Matthew M. Roden Matthew M. Roden (= 1×) peers Nicole Lévy

Countries citing papers authored by Matthew M. Roden

Since Specialization

Citations

This map shows the geographic impact of Matthew M. Roden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew M. Roden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew M. Roden more than expected).

Fields of papers citing papers by Matthew M. Roden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew M. Roden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew M. Roden. The network helps show where Matthew M. Roden may publish in the future.

Co-authorship network of co-authors of Matthew M. Roden

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew M. Roden. A scholar is included among the top collaborators of Matthew M. Roden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew M. Roden. Matthew M. Roden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Roden, Matthew M., et al.. (2005). Structural analysis of H2-Db class I molecules containing two different allelic forms of the type 1 diabetes susceptibility factor beta-2 microglobulin: Implications for the mechanism underlying variations in antigen presentation. Molecular Immunology. 43(9). 1370–1378. 2 indexed citations

2.

Ostrov, David A., Matthew M. Roden, Wuxian Shi, et al.. (2002). How H13 Histocompatibility Peptides Differing by a Single Methyl Group and Lacking Conventional MHC Binding Anchor Motifs Determine Self-Nonself Discrimination. The Journal of Immunology. 168(1). 283–289. 33 indexed citations

3.

Roden, Matthew M., et al.. (1999). A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology. Journal of Immunological Methods. 226(1-2). 29–41. 74 indexed citations

4.

Kaufman, Howard L., et al.. (1998). Splenectomy in a child with chronic Mycobacterium avium complex infection and splenic sequestration. Journal of Pediatric Surgery. 33(5). 761–763. 6 indexed citations

5.

Bettinotti, Maria, Christina J. Kim, Matthew M. Roden, et al.. (1998). Stringent Allele/Epitope Requirements for MART-1/Melan A Immunodominance: Implications for Peptide-Based Immunotherapy. The Journal of Immunology. 161(2). 877–889. 43 indexed citations

6.

Panelli, Monica C., Christina J. Kim, Adam I. Riker, et al.. (1998). Functional Dissociation Between Local and Systemic Immune Response During Anti-Melanoma Peptide Vaccination. The Journal of Immunology. 161(8). 4183–4194. 101 indexed citations

7.

Kim, Christina J., Matthew M. Roden, Linda Gritz, et al.. (1998). Use of recombinant poxviruses to stimulate anti-melanoma T cell reactivity. Annals of Surgical Oncology. 5(1). 64–76. 31 indexed citations

8.

Kim, Christina J., Willem W. Overwijk, Matthew M. Roden, et al.. (1997). Dendritic Cells Infected with PoxvIn Vitro iruses Encoding MART-1/ Melan A Sensitize T Lymphocytes In Vitro. Journal of Immunotherapy. 20(4). 276–286. 77 indexed citations

9.

Tatham, Thomas A., Matthew M. Roden, & James E. Barrett. (1997). Punishment alters the discriminative stimulus effects of midazolam.. Experimental and Clinical Psychopharmacology. 5(3). 171–182. 1 indexed citations

10.

Tatham, Thomas A., Matthew M. Roden, & James E. Barrett. (1997). Punishment alters the discriminative stimulus effects of midazolam.. Experimental and Clinical Psychopharmacology. 5(3). 171–182. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact